Dr Peggy Sue Huber, PSYD | |
2325 Clement Ave Ste A, Alameda, CA 94501-7061 | |
(510) 326-2622 | |
(510) 306-1062 |
Full Name | Dr Peggy Sue Huber |
---|---|
Gender | Female |
Speciality | Psychologist - Clinical |
Location | 2325 Clement Ave Ste A, Alameda, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700312667 | NPI | - | NPPES |
8121 | Medicaid | CA |
Mailing Address | Practice Location Address |
---|---|
Dr Peggy Sue Huber, PSYD 2325 Clement Ave Ste A, Alameda, CA 94501-7061 Ph: (510) 326-2622 | Dr Peggy Sue Huber, PSYD 2325 Clement Ave Ste A, Alameda, CA 94501-7061 Ph: (510) 326-2622 |
News Archive
Inova Diagnostics, a worldwide leader in autoimmune diagnostic reagents and systems for the clinical laboratory, is pleased to announce the US Food and Drug Administration clearance of QUANTA Lite Calprotectin Extended Range, an assay which aids in the diagnosis of Inflammatory Bowel Disease (IBD), and can help differentiate IBD from Irritable Bowel Syndrome (IBS).
The Fiscal Times reports on medical miracles and their place in the national health care reform debate with a likely subheading: high health care costs.
EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, announced today the execution of an amendment to its agreement with Opexa Therapeutics, Inc. for the development and commercialization of its investigational compound Tcelna (imilecleucel-T).
Many commentators have treated the Senate Finance bill as the likely template for any final legislation because it may be more palatable to conservative Democrats, and deficit hawks, in both houses.
DARA BioSciences announced today that it presented study results from its Phase 2 multicenter, placebo controlled, double-blind, randomized dose escalation study for KRN5500 at the 13th World Congress on Pain held recently in Montreal.
› Verified 7 days ago